PT Kalbe Farma Tbk. (IDX:KLBF)

Indonesia flag Indonesia · Delayed Price · Currency is IDR
1,430.00
0.00 (0.00%)
Aug 1, 2025, 4:13 PM WIB
Market Cap65.18T
Revenue (ttm)33.11T
Net Income (ttm)3.36T
Shares Out45.58B
EPS (ttm)72.97
PE Ratio19.60
Forward PE18.81
Dividend36.00 (2.52%)
Ex-Dividend DateJun 4, 2025
Volume77,411,800
Average Volume27,587,375
Open1,430.00
Previous Close1,430.00
Day's Range1,405.00 - 1,435.00
52-Week Range985.00 - 1,795.00
Beta0.01
RSI39.85
Earnings DateAug 1, 2025

About Marathon Oil

PT Kalbe Farma Tbk., together with its subsidiaries, develops, manufactures, and trades in pharmaceutical products in Indonesia. The company operates through Prescription Pharmaceuticals; Consumer Health; Nutritionals; and Distribution and Logistic divisions. The company provides prescription/ethical; consumer health; nutritionals; distribution and logistics; health services; medical devices; biopharma; animal health; international business; and E-health products. It operates Mitrasana Clinics, a health care service. In addition, the company pr... [Read more]

Sector Healthcare
Founded 1966
Employees 12,903
Stock Exchange Indonesia Stock Exchange
Ticker Symbol KLBF
Full Company Profile

Financial Performance

In 2024, PT Kalbe Farma Tbk.'s revenue was 32.63 trillion, an increase of 7.16% compared to the previous year's 30.45 trillion. Earnings were 3.24 trillion, an increase of 17.13%.

Financial numbers in GBP Financial Statements

News

There is no news available yet.